Posted by Michael Wonder on 21 Apr 2020
Swiss deal on cystic fibrosis drugs could change price negotiations
21 April 2020 - The deal is expected to help 400 eligible cystic fibrosis patients in Switzerland.
A long-awaited deal between Swiss public health authorities and US drug maker Vertex brings relief to cystic fibrosis sufferers in Switzerland. It may also pave the way for faster approval and fairer drug pricing.
“We have been waiting almost four years for this. It is very positive news for patients in Switzerland,” says Romain Benicchio, whose eight-year-old son has cystic fibrosis.
